Advances in the application of nicotinamide in dermatology

( views:1067, downloads:0 )
Author:
HUANG Tian(Dcpartmcnt of Dermatology,Second Affiliated Hospital of Dalian Univcrsity,Dalian 116027,China)
LIN Xi-ran()
Journal Title:
INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
Issue:
Volume 35, Issue 02, 2009
DOI:
10.3760/cma.j.issn.1673-4173.2009.02.010
Key Word:
Niacinamide;Skin diseases;Therapeutic uses

Abstract: Recent studies have shown that nicotinamide adenine dinucleotide(NAD)is not only a co-enzyme in cellular oxidation.reduction reactions.but also a substrate for reactions catalyzed by mono (ADP-ribose) transferases,poly (ADP-ribose) polymemses and acetylase,and it play important roles in numerous cellular physiologic functions.Nicotinamide is not only a precursor for the synthesis of NAD,but also an inhibitor of NAD-consuming enzymes.Besides pellagra,nicotinamide has been used to ireat immune bullous diseases,atopic dermatitis,rosacea and aene,and so on.Moreover,nicotinamide has shown a favorable perspective in anti-skin aging and cosmetic dermatology.The safety of topical nicotinamide has been already confirmed.but a forlnal safety evaluation routinely designed for a new drug has not been performed for oral nicotinamide at high dose.

  • [1]Daniel J,Marechal Y,Van Gool F,et al.Ncotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction.Biochem Pharmacol.2007,73(6):831-842.
  • [2]Namazi MR.Nicotinamide in dermatology:a capsule summary.Int J Dermatol,2007,46(12):1229-1231.
  • [3]Biedron R,Ciszek M,Tokarczyk M,et al.1-Methylnicotinamide and nicotinamide:two related anti-inflammatory agents that differentially affect the funcdons of activated macrophages.Arch Immunol Ther Exp(Wargz),2008,56(2):127-134.
  • [4]Benavente CA,Jacobsen EL.Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human kemtinoeytes.Free Radic Biol Med,2008,44(4):527-537.
  • [5]Draelos ZD.Clinical situations conducive to proaetive skin health and anti-aging improvement.J Investig Dermatol Symp Proc,2008,13(1):25-27.
  • [6]Kang HT,Lee HI,Hwang ES.Nicotinamide extends replicative lifespan of human cells.Aging Cell.2006,5(5):423-436.
  • [7]Bissett DL,Oblong JE,Berge CA.Niacinamide:A B vitamin that improves aging facial skin appearance.Dermatol Surg,2005,31(7 Pt 2):860-865.
  • [8]Chin PC,Chan CC,Lin HM,et al.The clinical anti-aging effects of topical kinetin and niacinamide in Asians:a randomized,double-blind,placebo-controlled,split-face comparative trial.J Cosmet Dermatol,2007,6(4):243-249.
  • [9]Draelos ZD,Matsubara A,Smiles K.The effect of 2% niacinamide on facial sebum production.J Cosmet Laser Ther,2006,8(2):96-101.
  • [10]Hegyi J,Schwartz RA,Hegyi V.Pellagra:dermatitis,dementia,and diarrhea.Int J Dermatol,2004,43(1):1-5.
  • [11]Tutrone WD,Spann CT,Scheinfeld N,et al.Polymorphic light emption.Dermatol Ther,2003,16(1):28-39.
  • [12]Damian DL,PaRerson CR,Stapelberg M,et al.UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.J Invest Dermatol,2008,128(2):447-454.
  • [13]Wojnarowska F,Kirtschig G,Highet AS,et al.British association of dermatologists.Guidelines for the management of bullous pemphigoid.Br J Dermatol,2002,147(2):214-221.
  • [14]Niren NM,Torok HM.The nicomide improvement in clinical outcomes study (NICOS):results of an 8-week triai.Cutis,2006,77(1 Suppl):17-28.
  • [15]Tirado-Sanchez A,León-Dorantes G.Treatment of pemphigus vulgads.An overview in Mexico.Allergol Immtmopathol (Madr),2006,34(1):10-16.
  • [16]Namazi MR.Nicotinamide as a potential addition to the anti-atopic dermatitis armamentarium.Int lmmunopharmacol,2004,4(6):709-712.
  • [17]Soma Y,Kashima M,Imaizumi A,et al.Moisturizing effects of topical nicotinamide on atopic dry skin.Int J Dermatol,2005,44(3):197-202.
  • [18]Cosmetic Ingredient Review Expert Panel.Final report of the safety assessment of niacinamide and niacin.Int J Toxicol,2005,24(Suppl 5):1-31.
  • [19]Knip M,Douek IF,Moore WP,et al.European nicotinamide diabetes intervention trial group.Safety of high-dose nicotinamide:a review.Diabetologia,2000,43(11):1337-1345.
  • [20]Gale EA,Bingley PJ,Emmett CL,et al.European nicotinamide diabetes ntervention trial (ENDIT) group.European nicotinamide diabetes intervention trial (ENDIT):a randomized ontrolled trial of intervention before the onset of type 1 diabetes.Lancet,2004,363(9413):925-931.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn